Down-regulation of MET, the receptor for hepatocyte growth factor

被引:0
|
作者
Dean E Hammond
Sylvie Urbé
George F Vande Woude
Michael J Clague
机构
[1] Physiological Laboratory,
[2] University of Liverpool,undefined
[3] Van Andel Research Institute,undefined
来源
Oncogene | 2001年 / 20卷
关键词
Met; hepatocyte growth factor; endocytosis; proteasome;
D O I
暂无
中图分类号
学科分类号
摘要
The ligand-dependent degradation of activated tyrosine kinase receptors provides a means by which mitogenic signalling can be attenuated. In many cell types the ligand-dependent degradation of the tyrosine kinase receptor Met is completely dependent on the activity of the 26S proteasome (Jeffers et al., 1997b). We now show that degradation also requires trafficking to late endosomal compartments and the activity of acid dependent proteases as determined by the effects of a dominant negative form of dynamin (K44A) and a vacuolar-ATPase inhibitor, concanamycin. We show that in the presence of the proteasome inhibitor lactacystin, Met fails to redistribute from the plasma membrane to intracellular compartments. This observation is most consistent with the interpretation that proteasome activity is required for Met internalization and only indirectly for its degradation.
引用
收藏
页码:2761 / 2770
页数:9
相关论文
共 50 条
  • [41] Dorsal Ruffle Microdomains Potentiate Met Receptor Tyrosine Kinase Signaling and Down-regulation
    Abella, Jasmine V.
    Parachoniak, Christine A.
    Sangwan, Veena
    Park, Morag
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (32) : 24956 - 24967
  • [42] Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering
    Li, Wenjing
    Dick, Adam
    Lu, Fei
    Zhang, Hui
    Sun, Hong
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [43] Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering
    Wenjing Li
    Adam Dick
    Fei Lu
    Hui Zhang
    Hong Sun
    Scientific Reports, 9
  • [44] Introduction: Hepatocyte Growth Factor and Met Receptor, from Discovery to Therapeutic Implications
    Nakamura, Toshikazu
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2011, 6 (02) : 143 - 145
  • [45] A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor
    Maestrini, E
    Tamagnone, L
    Longati, P
    Cremona, O
    Gulisano, M
    Bione, S
    Tamanini, F
    Neel, BG
    Toniolo, D
    Comoglio, PM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) : 674 - 678
  • [46] Inhibition of MET Receptor Tyrosine Kinase and Its Ligand Hepatocyte Growth Factor
    Sadiq, Ahad A.
    Geynisman, Daniel M.
    Salgia, Ravi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : S1810 - S1811
  • [47] Hepatocyte growth factor and its receptor c-met in multiple myeloma
    Borset, M
    HjorthHansen, H
    Seidel, C
    Sundan, A
    Waage, A
    BLOOD, 1996, 88 (10) : 3998 - 4004
  • [48] Pleiotropic actions of the hepatocyte growth factor and its tyrosine kinase receptor Met
    Tulasne, D
    Paumelle, R
    Fafeur, V
    M S-MEDECINE SCIENCES, 2001, 17 (02): : 232 - 237
  • [49] HEPATOCYTE GROWTH-FACTOR AND MET RECEPTOR EXPRESSION IN HUMAN PANCREATIC CARCINOGENESIS
    FURUKAWA, T
    DUGUID, WP
    KOBARI, M
    MATSUNO, S
    TSAO, MS
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (04): : 889 - 895
  • [50] Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density
    Pozner-Moulis, Sharon
    Pappas, Derek J.
    Rimm, David L.
    CANCER RESEARCH, 2006, 66 (16) : 7976 - 7982